Exelixis, Inc. (EXEL)
42.16
-2.20
(-4.95%)
USD |
NASDAQ |
Dec 08, 16:00
42.17
0.00 (0.00%)
After-Hours: 20:00
Exelixis Shareholders Equity (Quarterly): 2.161B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 466.00M |
| ADMA Biologics, Inc. | 431.19M |
| Aldeyra Therapeutics, Inc. | 49.24M |
| Merck & Co., Inc. | 51.85B |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.824B |
| Total Liabilities (Quarterly) | 662.85M |
| Debt to Equity Ratio | 0.0817 |
| Current Ratio | 3.752 |
| Net Debt Paydown Yield | 0.04% |